COPD Exacerbations Have Less Impact on Lung Function During Dupilumab Treatment
Автор: ACCP CHEST
Загружено: 2026-01-23
Просмотров: 55
Описание:
This study by Hanania et al. is a post-hoc analysis of pooled data from the BOREAS (NCT03930732) and NOTUS (NCT04456673) trials to assess whether dupilumab reduced the impact of exacerbations on lung function in patients who experienced ≥1 moderate or severe COPD exacerbations during the treatment period.
Sponsored by Sanofi. All opinions expressed and information provided as part of this program are those of the presenters only. The content of this program has not been reviewed by CHEST, and CHEST does not endorse or take any position regarding the contents, opinions, or information associated with this program.
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
